LifeVantage to Announce Second Quarter Fiscal Year 2023 Results on February 2, 2023
LifeVantage Corporation (Nasdaq: LFVN) will announce its financial results for the second quarter ended December 31, 2022, on February 2, 2023, after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LifeVantage Corporation (Nasdaq: LFVN) will announce its financial results for the second quarter ended December 31, 2022, on February 2, 2023, after the market closes. The company will host a conference call for investors at 2:30 p.m. MT (4:30 p.m. ET). Interested parties can call (877) 704-4453 in the U.S. or (201) 389-0920 internationally to participate. A replay will be available until February 9, 2023. Additionally, a live webcast will be accessible on the company’s Investor Relations website and archived for 30 days.
Positive
- Upcoming conference call on February 2, 2023, may provide key insights into financial performance.
- Live webcast options enhance accessibility for investors.
Negative
- None.
Details
News Market Reaction – LFVN
The recorded move for LFVN in the trading session of this news was +0.79%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, Jan. 19, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2022, after the stock market closes on Thursday, February 2, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February 9, 2023, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13735667, or (412) 317-6671 from international locations, and entering confirmation code 13735667.
There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1594115&tp_key=921deb41f0. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+™, ProBio™, IC Bright®, and Daily Wellness™ dietary supplements, the TrueScience® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.